1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Cell Therapy Manufacturing Market

4. Voice of Customer

4.1. Popularly used cells for Cell Therapy Manufacturing
4.2. Commonly Used Cell Therapies
4.3. Brand Awareness

5. Executive Summary

6. Global Cell Therapy Manufacturing Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies)
6.2.2. By Source of Cell (Autologous v/s Allogenic)
6.2.3. By Scale of Operation (Preclinical, Clinical, Commercial)
6.2.4. By Source (In-House v/s Contract Manufacturing)
6.2.5. By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others)
6.2.6. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Product Market Map

7. North America Cell Therapy Manufacturing Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Source of Cell
7.2.3. By Scale of Operation
7.2.4. By Source
7.2.5. By Application
7.2.6. By End User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Cell Therapy Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy
7.3.1.2.2. By Source of Cell
7.3.1.2.3. By Scale of Operation
7.3.1.2.4. By Source
7.3.1.2.5. By Application
7.3.1.2.6. By End User
7.3.2. Mexico Cell Therapy Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy
7.3.2.2.2. By Source of Cell
7.3.2.2.3. By Scale of Operation
7.3.2.2.4. By Source
7.3.2.2.5. By Application
7.3.2.2.6. By End User
7.3.3. Canada Cell Therapy Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy
7.3.3.2.2. By Source of Cell
7.3.3.2.3. By Scale of Operation
7.3.3.2.4. By Source
7.3.3.2.5. By Application
7.3.3.2.6. By End User

8. Europe Cell Therapy Manufacturing Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Source of Cell
8.2.3. By Scale of Operation
8.2.4. By Source
8.2.5. By Application
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. France Cell Therapy Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Source of Cell
8.3.1.2.3. By Scale of Operation
8.3.1.2.4. By Source
8.3.1.2.5. By Application
8.3.1.2.6. By End User
8.3.2. Germany Cell Therapy Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Source of Cell
8.3.2.2.3. By Scale of Operation
8.3.2.2.4. By Source
8.3.2.2.5. By Application
8.3.2.2.6. By End User
8.3.3. United Kingdom Cell Therapy Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Source of Cell
8.3.3.2.3. By Scale of Operation
8.3.3.2.4. By Source
8.3.3.2.5. By Application
8.3.3.2.6. By End User
8.3.4. Italy Cell Therapy Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy
8.3.4.2.2. By Source of Cell
8.3.4.2.3. By Scale of Operation
8.3.4.2.4. By Source
8.3.4.2.5. By Application
8.3.4.2.6. By End User
8.3.5. Spain Cell Therapy Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy
8.3.5.2.2. By Source of Cell
8.3.5.2.3. By Scale of Operation
8.3.5.2.4. By Source
8.3.5.2.5. By Application
8.3.5.2.6. By End User

9. Asia-Pacific Cell Therapy Manufacturing Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Source of Cell
9.2.3. By Scale of Operation
9.2.4. By Source
9.2.5. By Application
9.2.6. By End User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Cell Therapy Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy
9.3.1.2.2. By Source of Cell
9.3.1.2.3. By Scale of Operation
9.3.1.2.4. By Source
9.3.1.2.5. By Application
9.3.1.2.6. By End User
9.3.2. India Cell Therapy Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy
9.3.2.2.2. By Source of Cell
9.3.2.2.3. By Scale of Operation
9.3.2.2.4. By Source
9.3.2.2.5. By Application
9.3.2.2.6. By End User
9.3.3. South Korea Cell Therapy Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy
9.3.3.2.2. By Source of Cell
9.3.3.2.3. By Scale of Operation
9.3.3.2.4. By Source
9.3.3.2.5. By Application
9.3.3.2.6. By End User
9.3.4. Japan Cell Therapy Manufacturing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Therapy
9.3.4.2.2. By Source of Cell
9.3.4.2.3. By Scale of Operation
9.3.4.2.4. By Source
9.3.4.2.5. By Application
9.3.4.2.6. By End User
9.3.5. Australia Cell Therapy Manufacturing Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Therapy
9.3.5.2.2. By Source of Cell
9.3.5.2.3. By Scale of Operation
9.3.5.2.4. By Source
9.3.5.2.5. By Application
9.3.5.2.6. By End User

10. South America Cell Therapy Manufacturing Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Source of Cell
10.2.3. By Scale of Operation
10.2.4. By Source
10.2.5. By Application
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cell Therapy Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy
10.3.1.2.2. By Source of Cell
10.3.1.2.3. By Scale of Operation
10.3.1.2.4. By Source
10.3.1.2.5. By Application
10.3.1.2.6. By End User
10.3.2. Argentina Cell Therapy Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy
10.3.2.2.2. By Source of Cell
10.3.2.2.3. By Scale of Operation
10.3.2.2.4. By Source
10.3.2.2.5. By Application
10.3.2.2.6. By End User
10.3.3. Colombia Cell Therapy Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy
10.3.3.2.2. By Source of Cell
10.3.3.2.3. By Scale of Operation
10.3.3.2.4. By Source
10.3.3.2.5. By Application
10.3.3.2.6. By End User

11. Middle East and Africa Cell Therapy Manufacturing Market Outlook

11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Therapy
11.2.2. By Source of Cell
11.2.3. By Scale of Operation
11.2.4. By Source
11.2.5. By Application
11.2.6. By End User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Cell Therapy Manufacturing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapy
11.3.1.2.2. By Source of Cell
11.3.1.2.3. By Scale of Operation
11.3.1.2.4. By Source
11.3.1.2.5. By Application
11.3.1.2.6. By End User
11.3.2. Saudi Arabia Cell Therapy Manufacturing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapy
11.3.2.2.2. By Source of Cell
11.3.2.2.3. By Scale of Operation
11.3.2.2.4. By Source
11.3.2.2.5. By Application
11.3.2.2.6. By End User
11.3.3. UAE Cell Therapy Manufacturing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapy
11.3.3.2.2. By Source of Cell
11.3.3.2.3. By Scale of Operation
11.3.3.2.4. By Source
11.3.3.2.5. By Application
11.3.3.2.6. By End User

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Clinical Trials

16. Competitive Landscape

16.1. Competition Outlook
16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
16.2.1. KBI Biopharma, Inc.
16.2.2. Waisman Biomanufacturing
16.2.3. Cell and Gene Therapy Catapult
16.2.4. Thermo Fisher Scientific, Inc.
16.2.5. Merck KGaA
16.2.6. Catalent Inc.
16.2.7. Lonza Group
16.2.8. Oxford Biomedica Plc
16.2.9. Fujifilm Cellular Dynamics, Inc.
16.2.10. Wuxi Apptec
16.2.11. Charles River Laboratories International, Inc.
16.2.12. The Discovery Labs LLC
16.2.13. ABL, Inc.
16.2.14. BioCentriq
16.2.15. Commercializing Living Therapies

17. Strategic Recommendations

18. About Us & Disclaimer